Variable selection is crucial in high-dimensional omics-based analyses, since it is biologically reasonable to assume only a subset of non-noisy features contributes to the data structures. However, the task is particularly hard in an unsupervised setting, and a priori ad hoc variable selection is still a very frequent approach, despite the evident drawbacks and lack of reproducibility. We propose a Bayesian variable selection approach for rank-based unsupervised transcriptomic analysis. Making use of data rankings instead of the actual continuous measurements increases the robustness of conclusions when compared to classical statistical methods, and embedding variable selection into the inferential tasks allows complete reproducibility. Specifically, we develop a novel extension of the Bayesian Mallows model for variable selection that allows for a full probabilistic analysis, leading to coherent quantification of uncertainties. Simulation studies demonstrate the versatility and robustness of the proposed method in a variety of scenarios, as well as its superiority with respect to several competitors when varying the data dimension or data generating process. We use the novel approach to analyse genome-wide RNAseq gene expression data from ovarian cancer patients: several genes that affect cancer development are correctly detected in a completely unsupervised fashion, showing the usefulness of the method in the context of signature discovery for cancer genomics. Moreover, the possibility to also perform uncertainty quantification plays a key role in the subsequent biological investigation.
Lung cancer is the leading cause of the largest number of deaths worldwide and lung adenocarcinoma (LUAD) is the most common form of lung cancer. In this study, we carried out an integrated meta-analysis of the mutations including single-nucleotide variations (SNVs), the copy number variations (CNVs), RNA-seq and clinical data of patients with LUAD downloaded from The Cancer Genome Atlas (TCGA). We integrated significant SNV and CNV genes, differentially expressed genes (DEGs) and the DEGs in active subnetworks to construct a prognosis signature. Cox proportional hazards model (LOOCV) with Las…
Bayesian genome-wide clustering and variable selection of transcriptomic data via rank-based mixtures
Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo（奥斯陆大学生物统计与流行病学中心）；Department of Mathematics, University of Oslo（奥斯陆大学数学系）；Department of Economics and Statistics, University of Naples Federico II and CSEF（那不勒斯费德里科二世大学经济与统计系及CSEF）；The Norwegian Centre for Knowledge-driven Machine Learning, Integreat（挪威知识驱动机器学习中心）；Department of Cancer Genetics, Oslo University Hospital（奥斯陆大学医院癌症遗传学系）
In genome-wide prediction, independence of marker allele substitution effects is typically assumed; however, since early stages of this technology it has been known that nature points to correlated effects. In statistics, graphical models have been identified as a useful and powerful tool for covariance estimation in high dimensional problems and it is an area that has recently experienced a great expansion. In particular, Gaussian concentration graph models (GCGM) have been widely studied. These are models in which the distribution of a set of random variables, the marker effects in this case…
In many practices, scientists are particularly interested in detecting which of the predictors are truly associated with a multivariate response. It is more accurate to model multiple responses as one vector rather than separating each component one by one. This is particularly true for complex traits having multiple correlated components. A Bayesian multivariate variable selection (BMVS) approach is proposed to select important predictors influencing the multivariate response from a candidate pool with an ultrahigh dimension. By applying the sample-size-dependent spike and slab priors, the BM…
Bayesian variable selection regression (BVSR) is able to jointly analyze genome-wide genetic datasets, but the slow computation via Markov chain Monte Carlo (MCMC) hampered its wide-spread usage. Here we present a novel iterative method to solve a special class of linear systems, which can increase the speed of the BVSR model-fitting tenfold. The iterative method hinges on the complex factorization of the sum of two matrices and the solution path resides in the complex domain (instead of the real domain). Compared to the Gauss-Seidel method, the complex factorization converges almost instantan…
MINES ParisTech（巴黎高等矿业学院）；PSL Research University（巴黎文理研究大学）；Institut Curie（居里研究所）；INSERM（法国国家健康与医学研究院）；Ecole Normale Supérieure（巴黎高等师范学院）；CNRS（法国国家科学研究中心）
Single-cell RNA sequencing (scRNA-seq) is a fast growing approach to measure the genome-wide transcriptome of many individual cells in parallel, but results in noisy data with many dropout events. Existing methods to learn molecular signatures from bulk transcriptomic data may therefore not be adapted to scRNA-seq data, in order to automatically classify individual cells into predefined classes. We propose a new method called DropLasso to learn a molecular signature from scRNA-seq data. DropLasso extends the dropout regularisation technique, popular in neural network training, to esti- mate sp…
While the cost of sequencing genomes has decreased dramatically in recent years, this expense often remains non-trivial. Under a fixed budget, then, scientists face a natural trade-off between quantity and quality; they can spend resources to sequence a greater number of genomes (quantity) or spend resources to sequence genomes with increased accuracy (quality). Our goal is to find the optimal allocation of resources between quantity and quality. Optimizing resource allocation promises to reveal as many new variations in the genome as possible, and thus as many new scientific insights as possi…
The Dirichlet Process (DP) mixture model has become a popular choice for model-based clustering, largely because it allows the number of clusters to be inferred. The sequential updating and greedy search (SUGS) algorithm (Wang and Dunson, 2011) was proposed as a fast method for performing approximate Bayesian inference in DP mixture models, by posing clustering as a Bayesian model selection (BMS) problem and avoiding the use of computationally costly Markov chain Monte Carlo methods. Here we consider how this approach may be extended to permit variable selection for clustering, and also demons…
High-throughput genetic and epigenetic data are often screened for associations with an observed phenotype. For example, one may wish to test hundreds of thousands of genetic variants, or DNA methylation sites, for an association with disease status. These genomic variables can naturally be grouped by the gene they encode, among other criteria. However, standard practice in such applications is independent screening with a universal correction for multiplicity. We propose a Bayesian approach in which the prior probability of an association for a given genomic variable depends on its gene, and …
Statistical inference on the cancer-site specificities of collective ultra-rare whole genome somatic mutations is an open problem. Traditional statistical methods cannot handle whole-genome mutation data due to their ultra-high-dimensionality and extreme data sparsity -- e.g., >30 million unique variants are observed in the ~1700 whole-genome tumor dataset considered herein, of which >99% variants are encountered only once. To harness information in these rare variants we have recently proposed the "hidden genome model", a formal multilevel multi-logistic model that mines information in ultra-…
In genetic association studies, rare variants with extremely small allele frequency play a crucial role in complex traits, and the set-based testing methods that jointly assess the effects of groups of single nucleotide polymorphisms (SNPs) were developed to improve powers for the association tests. However, the powers of these tests are still severely limited due to the extremely small allele frequency, and precise estimations for the effect sizes of individual SNPs are substantially impossible. In this article, we provide an efficient set-based inference framework that addresses the two impo…
We introduce varbvs, a suite of functions written in R and MATLAB for regression analysis of large-scale data sets using Bayesian variable selection methods. We have developed numerical optimization algorithms based on variational approximation methods that make it feasible to apply Bayesian variable selection to very large data sets. With a focus on examples from genome-wide association studies, we demonstrate that varbvs scales well to data sets with hundreds of thousands of variables and thousands of samples, and has features that facilitate rapid data analyses. Moreover, varbvs allows for …
Heritability Estimation in Matrix-Variate Mixed models -- A Bayesian Approach
自全基因组关联研究（genome-wide association studies，GWASs）出现以来，线性混合模型方法被广泛应用于单核苷酸多态性（single nucleotide polymorphisms，SNPs）解释的狭义遗传力的估计。与大多数GWAS一样，大多数遗传力分析使用单变量方法进行，即独立考虑每个表型。在本研究中，我们提出了一种贝叶斯矩阵变量混合模型，除了通常通过相关性矩阵建模的个体之间的遗传相关性之外，还考虑了表型之间的遗传相关性。我们发现，当使用所有全基因组SNP估计相关矩阵时，我们的模型相当于效应量上具有矩阵正态先验的矩阵正态回归。使用真实数据，我们证明，当表型联合建模时（增加25-35%），遗传力会有所提高。事实上，基于其标准误，联合建模提供了比单变量建模更准确的遗传力估计。此外，与极大似然方法相比，我们的贝叶斯方法提供了略高的遗传力估计值。另一方面，虽然我们的方法在表型预测中表现不太好，但我们注意到初始插补步骤相对提高了预测准确性。
To date, genome-wide association studies (GWAS) have successfully identified tens of thousands of genetic variants among a variety of traits/diseases, shedding a light on the genetic architecture of complex diseases. Polygenicity of complex diseases, which refers to the phenomenon that a vast number of risk variants collectively contribute to the heritability of complex diseases with modest individual effects, have been widely accepted. This imposes a major challenge towards fully characterizing the genetic bases of complex diseases. An immediate implication of polygenicity is that a much larg…
Integrative network modeling of data arising from multiple genomic platforms provides insight into the holistic picture of the interactive system, as well as the flow of information across many disease domains including cancer. The basic data structure consists of a sequence of hierarchically ordered datasets for each individual subject, which facilitates integration of diverse inputs, such as genomic, transcriptomic, and proteomic data. A primary analytical task in such contexts is to model the layered architecture of networks where the vertices can be naturally partitioned into ordered layer…
Despite major methodological developments, Bayesian inference for Gaussian graphical models remains challenging in high dimension due to the tremendous size of the model space. This article proposes a method to infer the marginal and conditional independence structures between variables by multiple testing of hypotheses. Specifically, we introduce closed-form Bayes factors under the Gaussian conjugate model to evaluate the null hypotheses of marginal and conditional independence between variables. Their computation for all pairs of variables is shown to be extremely efficient, thereby allowing…
The location, timing, and abundance of gene expression (both mRNA and proteins) within a tissue define the molecular mechanisms of cell functions. Recent technology breakthroughs in spatial molecular profiling, including imaging-based technologies and sequencing-based technologies, have enabled the comprehensive molecular characterization of single cells while preserving their spatial and morphological contexts. This new bioinformatics scenario calls for effective and robust computational methods to identify genes with spatial patterns. We represent a novel Bayesian hierarchical model to analy…
Progress in probabilistic generative models has accelerated, developing richer models with neural architectures, implicit densities, and with scalable algorithms for their Bayesian inference. However, there has been limited progress in models that capture causal relationships, for example, how individual genetic factors cause major human diseases. In this work, we focus on two challenges in particular: How do we build richer causal models, which can capture highly nonlinear relationships and interactions between multiple causes? How do we adjust for latent confounders, which are variables infl…
It is well known that the integration among different data-sources is reliable because of its potential of unveiling new functionalities of the genomic expressions which might be dormant in a single source analysis. Moreover, different studies have justified the more powerful analyses of multi-platform data. Toward this, in this study, we consider the circadian genes' omics profile such as copy number changes and RNA sequence data along with their survival response. We develop a Bayesian structural equation modeling coupled with linear regressions and log normal accelerated failure time regres…
In this paper, we develop a graphical modeling framework for the inference of networks across multiple sample groups and data types. In medical studies, this setting arises whenever a set of subjects, which may be heterogeneous due to differing disease stage or subtype, is profiled across multiple platforms, such as metabolomics, proteomics, or transcriptomics data. Our proposed Bayesian hierarchical model first links the network structures within each platform using a Markov random field prior to relate edge selection across sample groups, and then links the network similarity parameters acro…
Integrative analysis of multi-level pharmacogenomic data for modeling dependencies across various biological domains is crucial for developing genomic-testing based treatments. Chain graphs characterize conditional dependence structures of such multi-level data where variables are naturally partitioned into multiple ordered layers, consisting of both directed and undirected edges. Existing literature mostly focus on Gaussian chain graphs, which are ill-suited for non-normal distributions with heavy-tailed marginals, potentially leading to inaccurate inferences. We propose a Bayesian robust cha…
Few Bayesian methods for analyzing high-dimensional sparse survival data provide scalable variable selection, effect estimation and uncertainty quantification. Such methods often either sacrifice uncertainty quantification by computing maximum a posteriori estimates, or quantify the uncertainty at high (unscalable) computational expense. We bridge this gap and develop an interpretable and scalable Bayesian proportional hazards model for prediction and variable selection, referred to as SVB. Our method, based on a mean-field variational approximation, overcomes the high computational cost of MC…
Supervised Bayesian joint graphical model for simultaneous network estimation and subgroup identification
School of Statistics and Data Science, Shanghai University of International Business and Economics（上海对外经贸大学统计与数据科学学院）；School of Statistics and Data Science, Shanghai University of Finance and Economics（上海财经大学统计与数据科学学院）；Department of Biostatistics, Yale School of Public Health（耶鲁公共卫生学院生物统计学系）
Network-based analyses of high-throughput genomics data provide a holistic, systems-level understanding of various biological mechanisms for a common population. However, when estimating multiple networks across heterogeneous sub-populations, varying sample sizes pose a challenge in the estimation and inference, as network differences may be driven by differences in power. We are particularly interested in addressing this challenge in the context of proteomic networks for related cancers, as the number of subjects available for rare cancer (sub-)types is often limited. We develop NExUS (Networ…
Selecting informative nodes over large-scale networks becomes increasingly important in many research areas. Most existing methods focus on the local network structure and incur heavy computational costs for the large-scale problem. In this work, we propose a novel prior model for Bayesian network marker selection in the generalized linear model (GLM) framework: the Thresholded Graph Laplacian Gaussian (TGLG) prior, which adopts the graph Laplacian matrix to characterize the conditional dependence between neighboring markers accounting for the global network structure. Under mild conditions, w…
MicroRNAs (miRNAs) are small non-coding RNAs that function as regulators of gene expression. In recent years, there has been a tremendous and growing interest among researchers to investigate the role of miRNAs in normal cellular as well as in disease processes. Thus to investigate the role of miRNAs in oral cancer, we analyse the expression levels of miRNAs to identify miRNAs with statistically significant differential expression in cancer tissues. In this article, we propose a novel Bayesian hierarchical model of miRNA expression data. Compelling evidences have demonstrated that the transcri…
We develop a Bayesian variable selection method, called SVEN, based on a hierarchical Gaussian linear model with priors placed on the regression coefficients as well as on the model space. Sparsity is achieved by using degenerate spike priors on inactive variables, whereas Gaussian slab priors are placed on the coefficients for the important predictors making the posterior probability of a model available in explicit form (up to a normalizing constant). The strong model selection consistency is shown to be attained when the number of predictors grows nearly exponentially with the sample size a…
In this work, we propose a scalable Bayesian procedure for learning the local dependence structure in a high-dimensional model where the variables possess a natural ordering. The ordering of variables can be indexed by time, the vicinities of spatial locations, and so on, with the natural assumption that variables far apart tend to have weak correlations. Applications of such models abound in a variety of fields such as finance, genome associations analysis and spatial modeling. We adopt a flexible framework under which each variable is dependent on its neighbors or predecessors, and the neigh…
VICatMix: variational Bayesian clustering and variable selection for discrete biomedical data
MRC Biostatistics Unit University of Cambridge East Forvie Building（医学研究理事会生物统计学单位剑桥大学东部大楼）；MRC Biostatistics Unit and CRUK Cambridge Centre Ovarian Programme and Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID) University of Cambridge（医学研究理事会生物统计学单位和癌症研究英国委员会剑桥中心卵巢计划及剑桥治疗免疫学和传染病研究所（CITIID）剑桥大学）
